EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers

Kun Xiang, Muhammad Akram, Walaa Fikry Elbossaty, Jinfu Yang, Chengming Fan iD

Heart Failure Reviews · 2022-07 · 27 (4) · 1211-1221

DOI: 10.1007/s10741-021-10142-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Heart Failure Reviews, online erschienen am 12.07.2021. Verfasst von Kun Xiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Middle Renmin Road 139, Changsha, 410011, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Exosomes, MicroRNAs. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 134 Literaturangaben. Gefördert von: Hunan Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF), the most common cardiac arrhythmia, is a global epidemic. AF can cause heart failure and myocardial infarction and increase the risk of stroke, disability, and thromboembolic events. AF is becoming increasingly ubiquitous and is associated with increased morbidity and mortality at higher ages, resulting in an increasing threat to human health as well as substantial medical and social costs. Currently, treatment strategies for AF focus on controlling heart rate and rhythm with medications to restore and maintain sinus rhythm, but this approach has limitations. Catheter ablation is not entirely satisfactory and does not address the issues underlying AF. Research exploring the mechanisms causing AF is urgently needed for improved prevention, diagnosis, and treatment of AF. Exosomes are small vesicles (30-150 nm) released by cells that transmit information between cells. MicroRNAs in exosomes play an important role in the pathogenesis of AF and are established as a biomarker for AF. In this review, a summary of the role of exosomes in AF is presented. The role of exosomes and microRNAs in AF occurrence, their therapeutic potential, and their potential role as clinical biomarkers is considered. A better understanding of exosomes has the potential to improve the prognosis of AF patients worldwide, reducing the global medical burden of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationExosomesMicroRNAsAnti-Arrhythmia AgentsBiomarkersHumans

Stichwörter der Autor:innen

Atrial fibrillationClinical biomarkerExosomesMicroRNA

Substanzen

Anti-Arrhythmia AgentsBiomarkersMicroRNAs

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Middle Renmin Road 139, Changsha, 410011, China.
  • Department of Eastern Medicine, Government College University Faisalabad, Faisalabad, Pakistan.
  • Biochemistry Department, Damietta University, Damietta, Egypt.
  • Department of Cardiovascular Surgery, the Second Xiangya Hospital, Central South University, Middle Renmin Road 139, Changsha, 410011, China. fanchengming@csu.edu.cn.

ORCID-Profile: Chengming Fan

Förderung

  • Hunan Provincial Science and Technology Department

Zitieren

APA

Xiang, K., Akram, M., Elbossaty, W. F., Yang, J., & Fan, C. (2022). Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers. Heart Failure Reviews, 27(4), 1211-1221. https://doi.org/10.1007/s10741-021-10142-5

Vancouver

Xiang K, Akram M, Elbossaty WF, Yang J, Fan C. Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers. Heart Failure Reviews. 2022;27(4):1211-1221. doi:10.1007/s10741-021-10142-5

BibTeX
@article{Xiang2022,
  author = {Xiang, Kun and Akram, Muhammad and Elbossaty, Walaa Fikry and Yang, Jinfu and Fan, Chengming},
  title = {Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers},
  journal = {Heart Failure Reviews},
  year = {2022},
  volume = {27},
  number = {4},
  pages = {1211--1221},
  doi = {10.1007/s10741-021-10142-5}
}
Kostenlos starten →